Unmet Medical Needs, Regulatory Barriers Addressed In Public Comments
This article was originally published in The Gray Sheet
Executive Summary
Device makers list drug-therapy monitoring tests, venous disease and diabetes treatments, and products targeting children and rare diseases among the top unmet public health priorities for FDA and other government agencies